Infection, Immunity and Aging: What the Evidence Shows
Immunosenescence, inflammaging, CMV, EBV, shingles vaccination and dementia, CHIP and the VALAD trial: what is established, what is emerging, what is hypothesis.
Condition
Testosterone optimization, hormone health, prostate care, and performance medicine. Evidence-based approaches to men's health beyond marketing.
How near-infrared photobiomodulation modulates neuroinflammation, restores mitochondrial function, and shows early clinical promise in Alzheimer's disease and dementia.
Four FDA/CDC-investigated Salmonella outbreaks linked to moringa leaf powder in 2025–2026, including a strain resistant to every recommended antibiotic. What happened, why, and what to do.
Chronic relational abuse rewires the HPA axis and blocks antidepressant response. Julian Douwes explains why the relationship is often the missing diagnosis in TRD.
The first individual-participant data analysis directly compares rTMS and esketamine for TRD. Here is what the evidence says, where it falls short, and how to choose.
Two FDA-approved at-home brain stimulation devices for depression are now available. Here is what the clinical evidence says and when they are — or are not — the right choice.
FDA warnings now cover 33+ weight-loss supplements adulterated with toxic yellow oleander. Here is what patients and physicians need to know to stay safe.
CRP and cytokine testing before TMS for depression identifies the inflamed subtype, predicts response, and guides whether inflammation must be treated first.
When TMS for depression takes weeks to build effect, IV ketamine can bridge the gap — acute relief while circuits remodel. Protocol, evidence, and patient selection.
SWIFT deep TMS and 5×5 accelerated rTMS compress depression treatment to 5–6 days. What the 2026 evidence shows, who qualifies, and how Julian positions these protocols.
Schedule a consultation to discuss your case with Dr. med. univ. Julian Douwes and the clinical team at St. George Hospital.
In-depth reference by Dr. med. univ. Julian Douwes
Men die, on average, five years earlier than women in virtually every developed country. They are more likely to die from nine of the ten leading causes of death. They are significantly less likely to seek preventive medical care, and when they do present, their conditions are often more advanced.
Much of this disparity is behavioral and systemic rather than biological: men are socialized to ignore symptoms, medical education has historically underemphasized male-specific hormonal health, and the healthcare system has not created pathways that encourage men to engage proactively with their health.
At St. George Hospital, we have developed a dedicated men’s health program because the hormonal, cardiovascular, metabolic and psychological sides of men’s health deserve the same rigorous, evidence-based attention that women’s health has rightly received over the past several decades. The aim is preventive and restorative medicine grounded in clinical evidence, rather than “anti-aging” vanity medicine.
No topic in men’s health generates more confusion than testosterone. There are those who treat it as a fountain of youth and those who consider it dangerous. The truth, as usual, is more nuanced.
For years, the primary concern about testosterone replacement therapy (TRT) was cardiovascular risk. The 2023 TRAVERSE trial, a large, randomized, placebo-controlled cardiovascular safety trial involving over 5,000 men, largely answered this concern for appropriately selected patients. The trial demonstrated no increased risk of major adverse cardiovascular events in men with hypogonadism receiving testosterone therapy compared to placebo. It did record more atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group, which belongs in any honest risk discussion.
Testosterone is still not risk-free. But in men with documented testosterone deficiency and symptoms consistent with hypogonadism, the cardiovascular fear that kept many physicians from prescribing TRT was not supported by rigorous evidence, and TRAVERSE changed the risk-benefit conversation.
Testosterone replacement is indicated when a man has both documented low testosterone levels (typically total testosterone below 300 ng/dL on multiple morning measurements, confirmed with free testosterone and SHBG) and symptoms consistent with deficiency: persistent fatigue, reduced libido, erectile dysfunction, loss of muscle mass, increased body fat, depressed mood, cognitive decline, or reduced bone density.
Both criteria must be met. A low number alone, without symptoms, does not necessarily require treatment. And symptoms alone, without laboratory confirmation, may have other causes that deserve investigation first.
At St. George Hospital, we use bioidentical testosterone, which is molecularly identical to the testosterone the body produces. This is administered via transdermal gel, intramuscular injection, or subcutaneous injection, depending on patient preference and pharmacokinetic goals.
We do not use synthetic androgens or anabolic steroids. The goal is physiologic replacement: restoring levels to the healthy range without pushing them to supraphysiologic concentrations, which matters for both efficacy and safety.
Responsible testosterone therapy requires consistent monitoring. We check the following at regular intervals:
This monitoring is non-negotiable. Prescribing testosterone without regular blood work is irresponsible medicine.
Testosterone, while important, is only one component of male hormonal health. A full evaluation addresses several additional axes.
Dehydroepiandrosterone (DHEA) is the most abundant steroid hormone in the body and serves as a precursor to both testosterone and estrogen. DHEA levels decline steadily from age 25 onward, and low levels are associated with reduced immune function, fatigue, decreased sense of well-being, and loss of bone density. We measure DHEA-S (the sulfated, stable form) and supplement cautiously when levels are suboptimal.
Thyroid dysfunction in men is underdiagnosed because it is considered “a women’s disease.” Subclinical hypothyroidism in men contributes to fatigue, weight gain, cognitive sluggishness, depression and elevated cholesterol. We assess the complete thyroid panel (TSH plus free T3, free T4, reverse T3 and thyroid antibodies) because a normal TSH can mask meaningful functional thyroid insufficiency.
Growth hormone (GH) declines progressively with age, contributing to reduced muscle mass, increased visceral fat, thinning skin, decreased exercise capacity, and impaired recovery. We assess GH status through IGF-1 levels and, where indicated, provocative stimulation testing. When deficiency is documented, we discuss the evidence, risks, and benefits of GH therapy with full transparency. Growth hormone therapy is a regulated treatment in Germany and is prescribed only for documented deficiency, not as a lifestyle enhancement.
Chronic stress disrupts the diurnal cortisol pattern, and many men presenting with fatigue, abdominal weight gain, insomnia, and reduced stress tolerance have measurable HPA axis dysregulation. We assess this through four-point salivary cortisol testing, which maps the cortisol curve throughout the day. Treatment addresses root causes (stress management, sleep optimization, adaptogenic support) rather than simply suppressing cortisol.
Prostate-specific antigen (PSA) testing remains controversial, and I think the controversy has done men a disservice. The US Preventive Services Task Force initially recommended against routine PSA screening, then revised its position to recommend shared decision-making. The problem was how results were acted upon, which led to overdiagnosis and overtreatment of indolent cancers.
My position is that informed PSA testing, interpreted in context (PSA velocity, free-to-total PSA ratio, age-specific reference ranges, and prostate health index where available), remains a valuable tool for early detection when combined with clinical judgment. The key is nuanced interpretation, not abandonment of screening.
BPH affects the majority of men over 50 and significantly impacts quality of life through urinary frequency, urgency, nocturia, and incomplete emptying. We address BPH through a combination of targeted botanicals with evidence (saw palmetto extract standardized to 85-95% fatty acids, beta-sitosterol), lifestyle modifications (reduced evening fluid intake, pelvic floor exercises), and conventional medications (5-alpha reductase inhibitors, alpha-blockers) when indicated.
Prostate cancer prevention draws on epidemiological evidence: maintaining a healthy body weight, regular physical activity, adequate selenium and vitamin D status, consumption of lycopene-rich foods, and management of chronic inflammation all appear to confer protective benefit. We build these strategies into our men’s health programs.
Sexual dysfunction is one of the most common reasons men seek medical attention, yet it remains surrounded by stigma that prevents honest clinical discussion. I approach this topic the same way I approach cardiovascular disease or metabolic syndrome: as a medical issue that deserves proper diagnosis and treatment.
Erectile dysfunction (ED) in men over 40 is frequently a vascular problem. The penile arteries are among the smallest in the body, and endothelial dysfunction manifests there before it manifests in the coronary arteries. ED has been demonstrated to precede cardiovascular events by an average of 3-5 years, making it an important early warning sign.
Our evaluation of ED includes vascular assessment (carotid intima-media thickness, endothelial function), hormonal evaluation (testosterone, thyroid, prolactin), and psychological screening. Treatment addresses root causes (hormone optimization, vascular health, stress management) rather than simply prescribing phosphodiesterase inhibitors, though these medications remain useful tools in the appropriate context.
Libido, ejaculatory function, and overall sexual satisfaction are also addressed within the hormone optimization framework. Low testosterone, elevated prolactin, thyroid dysfunction, and medication side effects are all common and treatable causes of sexual complaints.
Heart disease is the leading killer of men worldwide, and the standard lipid panel (total cholesterol, LDL, HDL, triglycerides) is insufficient for proper risk assessment. Many men who experience cardiac events have “normal” standard lipid values.
We advocate for advanced cardiovascular testing:
Every man over 40 should know his ApoB and Lp(a) levels. If Lp(a) is elevated, aggressive management of other modifiable risk factors becomes essential. If the CAC score is non-zero, the conversation about treatment intensity changes significantly.
Sarcopenia, the age-related loss of muscle mass and strength, begins in the fourth decade and accelerates after age 60. It is associated with increased fracture risk, metabolic dysfunction, insulin resistance, reduced functional independence, and increased mortality.
Prevention and treatment are straightforward in principle:
Resistance training is the single most effective intervention. Progressive overload through compound movements (squat, deadlift, press, row) 2-4 times weekly, with appropriate programming for age and fitness level, is more impactful than any supplement or medication.
Protein intake of 1.6-2.2 grams per kilogram of body weight per day, distributed across meals, provides the amino acid substrate necessary for muscle protein synthesis. Most men over 40 consume inadequate protein.
Creatine monohydrate (3-5 grams daily) is the most well-studied performance supplement in existence, with decades of safety data. It improves strength, power output, and muscle hydration, and emerging evidence suggests neuroprotective benefits.
Testosterone optimization, as discussed above, supports muscle maintenance and growth. GH assessment is relevant in cases of severe sarcopenia with documented deficiency.
Men are roughly four times more likely to die by suicide than women, yet far less likely to seek help for depression, anxiety, or cognitive decline. This is a public health crisis that the medical profession has been slow to address.
At St. George Hospital, we approach men’s mental health from a physiological foundation. Testosterone deficiency is strongly associated with depressive symptoms, irritability and cognitive decline, and in many cases hormone optimization produces meaningful improvement in mood and mental clarity without antidepressant medication. Not all male depression is hormonal, but the hormonal axis should be evaluated before or alongside psychological treatment.
We also offer neurofeedback training, a non-invasive technique that uses real-time EEG feedback to help patients improve brainwave regulation. Neurofeedback has a growing evidence base for attention, executive function, stress resilience, and sleep quality. For men who are reluctant to engage with traditional therapy, neurofeedback offers a technology-based entry point into brain health optimization.
Cognitive performance (memory, processing speed, executive function) is also addressed through cardiovascular optimization (the brain depends on vascular health), sleep improvement, targeted supplementation (omega-3 fatty acids, phosphatidylserine, lion’s mane extract in appropriate cases), and metabolic optimization.
For men who also want to work on long-term healthspan, we offer evidence-based longevity-focused assessments and interventions.
Exercise programming: A combination of resistance training, zone 2 cardiovascular training (3-4 hours weekly), and VO2 max efforts has the strongest evidence base for all-cause mortality reduction. We provide exercise prescriptions based on current fitness testing and goals.
Metabolic health: Fasting insulin, HbA1c, continuous glucose monitoring data, and HOMA-IR assessment guide dietary and lifestyle recommendations. Metabolic health is arguably the most modifiable determinant of healthspan.
Targeted supplementation: Based on individual lab results, we may recommend specific evidence-supported supplements: vitamin D (titrated to 40-60 ng/mL), magnesium, omega-3 fatty acids, creatine, and others as indicated by testing. We do not recommend large, untargeted supplement regimens.
Sleep optimization: Sleep is the foundation of recovery, hormone production, cognitive function, and immune health. We assess and optimize sleep architecture through a combination of behavioral strategies, environmental modifications, and targeted interventions.
Our men’s health program combines evaluation and treatment. It begins with an extensive initial consultation and laboratory workup, followed by a personalized treatment plan that addresses the specific areas where intervention will have the greatest impact.
We see men at every stage: those in their 40s who want to optimize proactively, those in their 50s and 60s dealing with hormone decline and emerging health concerns, and men of any age with specific complaints, such as fatigue, sexual dysfunction, cognitive decline or body composition changes, that deserve thorough investigation.
What distinguishes our approach is the integration of endocrinology, functional medicine, cardiovascular risk assessment, and performance optimization into a single, coherent program. Rather than seeing a urologist for prostate concerns, an endocrinologist for hormones, a cardiologist for heart risk, and a psychiatrist for mood, you work with a medical team that understands how these systems interconnect.
If you would like to learn more about our men’s health programs or discuss whether an evaluation would be appropriate for your situation, please contact our international patient team at info@clinicum-stgeorg.de or +49 (0)8061 398-0. Consultations can be arranged in person at our hospital in Bad Aibling, Germany, or as a preliminary remote consultation to determine next steps.
Everything else in your life depends on your health, and understanding it is worth the investment.